Managed Healthcare Executive10h
AI Model Shows Promise in Reducing Skin Cancer Detection Bias
A novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or ...
Cosmo and Glenmark Announce UK MHRA Approval of Winlevi® for Treatment of Acne
Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Glenmark Pharmaceuticals Limited (Glenmark), a global ...
poultryworld18h
Partial replacement of soybean oil by insect oil in broiler diets
In a broiler field study, 1% of soybean oil was replaced with black soldier fly oil. Growth performance of the the broilers, ...
Legit on MSN15h
50 ugly cartoon characters memorable thanks to their design
Looking for ugly cartoon characters with interesting personalities? Read on and discover some of the ugly cartoons that will ...
The silent cancer that kills 70% of people within a year - the three questions to check your risk
Tragically, it claims the lives of 9,558 people annually, with over 70% succumbing within a year of being diagnosed. Just one ...
Three questions to check your risk of silent cancer that kills 70% within a year
Sadly the disease will kill 9,558 people every year with just over 70% dying within 12 months of their diagnosis. One in 10 ...
Cosmo and Glenmark Announces UK MHRA Approval of Winlevi(R) for Treatment of Acne
Dublin, Ireland and Mumbai, India and London, United Kingdom--( - February 10, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) and Glenmark Pharmaceuticals Limited (Glenmark), a ...
Multiple Sclerosis News Today7h
MS patients highly satisfied with Sensoready autoinjector pen
Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...